Exact Mass: 189.12973239999997
Exact Mass Matches: 189.12973239999997
Found 486 metabolites which its exact mass value is equals to given mass value 189.12973239999997,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Castanospermine
Castanospermine is a tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer). It has a role as a metabolite, an anti-HIV-1 agent, an anti-inflammatory agent and an EC 3.2.1.* (glycosidase) inhibitor. Castanospermine is a natural product found in Alexa grandiflora, Alexa wachenheimii, and other organisms with data available. A tetrahydroxyindolizidine alkaloid that consists of octahydroindolizine having four hydroxy substituents located at positions 1, 6, 7 and 8 (the 1S,6S,7R,8R,8aR-diastereomer). D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors KEIO_ID C043 Castanospermine inhibits all forms of α- and β-glucosidases, especially glucosidase L.
Homocitrulline
Homocitrulline is a metabolite that can be detected in larger amounts in the urine of individuals with urea cycle disorders (OMIM 238970). The accumulation of carbamylphosphate due to depleted supply of ornithine for the urea cycle may be responsible for the enhanced synthesis of homocitrulline and homoarginine in some cases (PMID 2474087). Homocitrulline has been identified in the human placenta (PMID: 32033212). Homocitrulline is a metabolite that can be detected in larger amounts in the urine of individuals with urea cycle disorders (OMIM 238970). The accumulation of carbamylphosphate due to depleted supply of ornithine for the urea cycle may be responsible for the enhanced synthesis of homocitrulline and homoarginine in some cases (PMID 2474087). [HMDB] L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI). L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI).
N-Nitrosoanatabine
C10H11N3O (189.09020759999999)
N-Lactoylvaline
N-Lactoylvaline is a lactoyl derivative of phenylalanine. N-Lactoyl-amino acids are ubiquitous pseudodipeptides of lactic acid and amino acids that are rapidly formed by reverse proteolysis. A protease, cytosolic nonspecific dipeptidase 2 (CNDP2), catalyzes their formation. The plasma levels of these metabolites strongly correlate with plasma levels of lactate and amino acid (PMID: 25964343).
N-Methylcalystegine B2
N-Methylcalystegine B2 is an alkaloid from the roots of Lycium chinense (Chinese boxthorn). Alkaloid from the roots of Lycium chinense (Chinese boxthorn)
S-Prenyl-L-cysteine
S-Prenyl-L-cysteine is catalysed by prenylcysteine oxidase to form L-cysteine.A flavoprotein (FAD). Cleaves the thioether bond of S-prenyl-L-cysteines, such as S-farnesylcysteine and S-geranylgeranylcysteine. N-Acetyl-prenylcysteine and. prenylcysteinyl peptides are not substrates. This reaction may represent the final. step in the degradation of prenylated proteins in mammalian tissues. The enzyme is originally thought to be a simple lyase so it had been classified as. EC 4.4.1.18. S-Prenyl-L-cysteine is catalysed by prenylcysteine oxidase to form L-cysteine.A flavoprotein (FAD). Cleaves the thioether bond of S-prenyl-L-cysteines, such as S-farnesylcysteine and S-geranylgeranylcysteine. N-Acetyl-prenylcysteine and
1-hydroxyhexanoylglycine
1-Hydroxyhexanoylglycine is classified as a member of the Alpha amino acids. Alpha amino acids are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). 1-Hydroxyhexanoylglycine is considered to be soluble (in water) and acidic.ÂÂ
2-hydroxyhexanoylglycine
2-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 2-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
3-hydroxyhexanoylglycine
3-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 3-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
4-hydroxyhexanoylglycine
4-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 4-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
5-hydroxyhexanoylglycine
5-Hydroxyhexanoylglycine is classified as a member of the N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. 5-Hydroxyhexanoylglycine is considered to be slightly soluble (in water) and acidic.
1-Carboxyethylvaline
1-Carboxyethylvaline belongs to the class of organic compounds known as valine and derivatives. These are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 1-Carboxyethylvaline was identified as one of forty plasma metabolites that could be used to predict gut microbiome Shannon diversity (PMID: 31477923). Shannon diversity is a metric that summarizes both species abundance and evenness, and it has been suggested as a marker for microbiome health.
1-(2,7-dimethylpyrazolo[1,5-a]pyrimidin-6-yl)ethanone
C10H11N3O (189.09020759999999)
5-methyl-N-(pyridin-3-ylmethyl)isoxazol-3-amine
C10H11N3O (189.09020759999999)
Me glcoside-beta-D-Pyranose-3-(Dimethylamino)-2,3,6-trideoxy-arabino-hexose|Me glycoside-alpha-D-Pyranose-3-(Dimethylamino)-2,3,6-trideoxy-arabino-hexose
1,2,3,4,7-Pentahydroxy-6-nitrobicyclo[3.3.0]octane
1,2-O-Isopropylidene-alpha-D-Furanose-3-Amino-3-deoxyribose
2-amino-5-[[amino(hydrazinyl)methylidene]amino]pentanoic acid
C6H15N5O2 (189.12256900000003)
L-Homocitrulline
A L-lysine derivative that is L-lysine having a carbamoyl group at the N(6)-position. It is found in individuals with urea cycle disorders. L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI). L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI).
Homocitrulline
L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI). L-Homocitrulline is metabolized to homoarginine through homoargininosuccinate via the urea cycle pathway and its metabolic abnormality could lead to Lysinuric Protein Intolerance (LPI).
1H-Benzimidazole-2-propanamide(9CI)
C10H11N3O (189.09020759999999)
Cyclopentanecarboxylic acid, 4-amino-2,3-dihydroxy-, ethyl ester,
7,9-Dimethyl-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one
n-Butyl-1h-benzimidazol-2-amine
M084 is a benzimidazole derivative. M084 inhibits the mitochondrial respiration, activate mitochondrial unfolded protein response and AMPK, recruites SIR-2.1 and SKN-1, and finally through the transcription factor DAF-16, delays the aging process of C. elegans[1].
1H-Benzimidazole-1-methanamine,N,N,2-trimethyl-(9CI)
2-(3-(PYRIDIN-4-YL)-1H-PYRAZOL-1-YL)ETHANOL
C10H11N3O (189.09020759999999)
2-(4-aminophenyl)-3-methyl-1H-pyrazol-5-one
C10H11N3O (189.09020759999999)
[3-(aminomethyl)phenyl]methanamine,prop-2-enenitrile
3-(7-METHYL-IMIDAZO[1,2-A]PYRIDIN-2-YL)-PHENYLAMINE
3-AMINO-2-ETHYL-4(3H)-QUINAZOLINONE
C10H11N3O (189.09020759999999)
1-(2,2-Dimethyl-1-phenylcyclopropyl)-N-methylmethanamine
1-(4-METHOXY-PHENYL)-1H-PYRAZOL-3-YLAMINE
C10H11N3O (189.09020759999999)
2-(3-aminophenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-one
C10H11N3O (189.09020759999999)
2-(methylaminomethyl)-1H-quinazolin-4-one
C10H11N3O (189.09020759999999)
(5-Methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methanol
C10H11N3O (189.09020759999999)
2-(4-Morpholinyl)Isonicotinonitrile
C10H11N3O (189.09020759999999)
4-(4-METHOXYPHENYL)-1H-PYRAZOL-3-AMINE
C10H11N3O (189.09020759999999)
b-Alanine,N-(3-hydrazino-3-oxopropyl)-, hydrazide (9CI)
C6H15N5O2 (189.12256900000003)
1H-Benzimidazol-2-amine,1-(1,1-dimethylethyl)-(9CI)
Carbamic acid, (3-hydroxybutyl)-, 1,1-dimethylethyl ester (9CI)
N-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-L-(1-13C)Alanine
(2-BENZHYDRYLOXYCARBONYLAMINO-6-OXO-1,6-DIHYDRO-PURIN-9-YL)-ACETICACID
C10H11N3O (189.09020759999999)
(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)METHANOL
C10H11N3O (189.09020759999999)
[2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
2-[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]ethanamine
Pyrido[2,3-b]pyrazine-2,3-diamine, N,N-dimethyl- (9CI)
Carbamic acid, (2-hydroxy-1-methylpropyl)-, 1,1-dimethylethyl ester (9CI)
N-[2-(tert-Butyldimethylsilyloxy)ethyl]methylamine
(CIS/TRANS)-2,5-DIMETHYL-1-N-(4-METHYL)PHENYLPYRROLIDINE
Ethanone,1-(5,6,7,8-tetrahydro-2-naphthalenyl)-, oxime
[4-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
9-Azabicyclo[3.3.1]nonan-3-one,9-methyl-, hydrochloride (1:1)
[(1S,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropyl]methylazanium
5-(3-Methoxyphenyl)-1H-iMidazol-2-aMine
C10H11N3O (189.09020759999999)
5-(4-Methoxyphenyl)-1H-imidazol-2-amine
C10H11N3O (189.09020759999999)
Pyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-one, 6a,7,8,9-tetrahydro- (9CI)
C10H11N3O (189.09020759999999)
4-(5-ethyl-1,2,4-oxadiazol-3-yl)aniline
C10H11N3O (189.09020759999999)
2-AMINO-EXO-1,3,3-TRIMETHYLBICYCLO[2.2.1]HEPTANE HYDROCHLORIDE
5-(3-Methoxyphenyl)-2H-pyrazol-3-ylamine
C10H11N3O (189.09020759999999)
METHYL-(3-PHENYL-[1,2,4]OXADIAZOL-5-YLMETHYL)-AMINE
C10H11N3O (189.09020759999999)
1-ETHYL-1,2,3,4-TETRAHYDRO-QUINOLINE-6-CARBALDEHYDE
C-(3-Benzyl-[1,2,4]oxadiazol-5-yl)-methylaminehydrochloride
C10H11N3O (189.09020759999999)
5-(2-Methoxy-phenyl)-1H-pyrazol-3-ylamine
C10H11N3O (189.09020759999999)
5-(2-Methoxyphenyl)-1H-pyrazol-3-amine
C10H11N3O (189.09020759999999)
4-amino-2-pyrrolidin-1-ylpyrimidine-5-carbonitrile
2-(4-AMINOMETHYL-OXAZOL-2-YL)-PHENYLAMINE
C10H11N3O (189.09020759999999)
ALLYL-(3-METHYL-1,1-DIOXO-TETRAHYDRO-1LAMBDA6-THIOPHEN-3-YL)-AMINE
1-ethyl-3-hydrazono-1,3-dihydro-indol-2-one
C10H11N3O (189.09020759999999)
1H-Imidazo[1,2-a]benzimidazole,2,3-dihydro-6-methoxy-(9CI)
C10H11N3O (189.09020759999999)
3H-Pyrazol-3-one,2-(4-aminophenyl)-2,4-dihydro-5-methyl-
C10H11N3O (189.09020759999999)
1-(IMIDAZO[1,2-A]PYRIDIN-2-YL)-2-METHYLPROPAN-2-AMINE
tert-Butyl (N-hydroxycarbamimidoylmethyl)carbamate
2-amino-2-cyano-n-p-toylyl-acetamide
C10H11N3O (189.09020759999999)
5-methoxy-1h-indole-3-carboxamidine
C10H11N3O (189.09020759999999)
1-METHYL-1H-INDOLE-3-CARBOHYDRAZIDE
C10H11N3O (189.09020759999999)
(1R,2S)-1,7,7-Trimethylbicyclo[2.2.1]hept-2-ylamine hydrochloride
(5-benzyl-1,2,4-oxadiazol-3-yl)methanamine
C10H11N3O (189.09020759999999)
1-(4-METHOXYBENZYL)-1,2,4-TRIAZOLE
C10H11N3O (189.09020759999999)
2-(2-Methyl-2-propanyl)-1H-pyrrolo[2,3-b]pyridin-5-amine
3-(4-Methoxyphenyl)-1H-pyrazol-5-amine
C10H11N3O (189.09020759999999)
1H-Benzimidazole-2-methanamine,N,N,1-trimethyl-(9CI)
Pyrido[2,3-b]pyrazin-2(1H)-one, 3-(1-methylethyl)- (9CI)
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-3(4H)-one, 2-(1-methylethyl)- (9CI)
C10H11N3O (189.09020759999999)
Pyrido[2,3-b]pyrazin-6(4H)-one, 3-amino-8-methyl- (9CI)
C10H11N3O (189.09020759999999)
(2-imidazol-1-yl-6-methylpyrimidin-4-yl)methanamine
1H-Benzimidazole-2-acetamide,N-methyl-(9CI)
C10H11N3O (189.09020759999999)
2-(2-AMINOETHYL)QUINAZOLIN-4(3H)-ONE
C10H11N3O (189.09020759999999)
N-ETHYL-N-ISOPROPYLPROPAN-2-AMINE TRIHYDROFLUORIDE
[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]methanamine
C10H11N3O (189.09020759999999)
[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methanamine
C10H11N3O (189.09020759999999)
1H-Benzimidazole-2-methanamine,alpha-(1-methylethyl)-,(S)-(9CI)
3-(DIETHYLENETRIAMINO)PROPYL-FUNCTIONALIZED SILICA GEL
C7H19N3OSi (189.12973239999997)
1-(4-Methoxybenzyl)-1H-1,2,4-triazole
C10H11N3O (189.09020759999999)
Azolimine
C10H11N3O (189.09020759999999)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic
3-Isocyanatopropyltrimethoxysilane
C7H15NO3Si (189.08211599999998)
Pyrimido[1,2-a]benzimidazol-8-ol, 1,2,3,4-tetrahydro- (9CI)
C10H11N3O (189.09020759999999)
2-ISOPROPYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-6-CARBALDEHYDE
C10H11N3O (189.09020759999999)
1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-AMINE HYDROCHLORIDE
Pyrido[2,3-b]pyrazin-3(4H)-one, 2,6,8-trimethyl- (9CI)
C10H11N3O (189.09020759999999)
1H-Benzimidazole-1-carboxamide,N,N-dimethyl-(9CI)
C10H11N3O (189.09020759999999)
1H-Benzimidazole-1-acetamide,2-methyl-(9CI)
C10H11N3O (189.09020759999999)
Pyrrolidine, 1-(2-chloro-1-oxopropyl)-2,2-dimethyl- (9CI)
methyl-(5-phenyl-[1,3,4]oxadiazol-2-ylmethyl)-amine
C10H11N3O (189.09020759999999)
1-isopropyl-1h-benzo[d][1,2,3]triazole-5-carbaldehyde
C10H11N3O (189.09020759999999)
1H-Benzimidazol-5-amine,2-(1,1-dimethylethyl)-(9CI)
4-(4-hydroxyphenyl)-5-methyl-1,3-hiazol-2-amine
C10H11N3O (189.09020759999999)
(5-METHYL-4,5-DIHYDRO-1H-PYRAZOL-1-YL)(PYRIDIN-3-YL)METHANONE
C10H11N3O (189.09020759999999)
spiro[1,3-dihydroimidazo[4,5-b]pyridine-2,1-cyclohexane]
2-(3-(pyridin-2-yl)-1H-pyrazol-1-yl)ethanol
C10H11N3O (189.09020759999999)
[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]METHANOL
C10H11N3O (189.09020759999999)
3,4,6-trideuterio-5-[1,2,2-trideuterio-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
C9H7D6NO3 (189.12720186800001)
Quinoline,1-acetyl-1,2,3,4-tetrahydro-4-methyl- (9CI)
4-(4-AMINOMETHYL-OXAZOL-2-YL)-PHENYLAMINE
C10H11N3O (189.09020759999999)
4-methoxy-1h-indole-3-carboxamidine
C10H11N3O (189.09020759999999)
2-(3-PHENYL-[1,2,4]OXADIAZOL-5-YL)-ETHYLAMINE
C10H11N3O (189.09020759999999)
Oxazole,4,5-dihydro-4,4-dimethyl-2-(phenylmethyl)-
1H-Benzimidazol-7-amine,2-methyl-1-(1-methylethyl)-(9CI)
N,N-dimethyl-1H-indazole-3-carboxamide
C10H11N3O (189.09020759999999)
6-morpholin-4-ylpyridine-2-carbonitrile
C10H11N3O (189.09020759999999)
2-methyl-5-(1-methylpyrazol-4-yl)pyridin-3-ol
C10H11N3O (189.09020759999999)
9-Methyl-5,6,7,8-tetrahydrotetrazolo[5,1-b]quinazoline
Trimethylsilyl (acetylamino)acetate
C7H15NO3Si (189.08211599999998)
n-trimethyllysine
C9H21N2O2+ (189.16029460000001)
D050258 - Mitosis Modulators > D008934 - Mitogens
3-Formyl-2-hydroxy-5-methyl-hexanoic acid hydroxyamide
2-{[Formyl(hydroxy)amino]methyl}-4-methylpentanoic acid
(2R)-2-{[Formyl(hydroxy)amino]methyl}hexanoic acid
N-Methyl-N-[(1R)-1-methyl-2-phenylethyl]prop-2-EN-1-amine
(S)-2-Amino-6-(trimethylammonio)hexanoic acid
C9H21N2O2+ (189.16029460000001)
D050258 - Mitosis Modulators > D008934 - Mitogens COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2S)-2-ammonio-5-{[iminio(methylamino)methyl]amino}pentanoate
The zwitterionic form of N(omega)-methyl-L-arginine in which the imino nitrogen has been protonated.
(2S)-6-{[amino(iminio)methyl]amino}-2-azaniumylhexanoate
(2S)-2-azanyl-5-(3-azanylpropylamino)pentanoic acid
S-Prenyl-L-cysteine
A prenylcysteine where the prenyl moiety is attached to the side-chain sulfur atom of L-cysteine.
(2S)-2-[[(1R)-1-carboxyethyl]amino]-3-methylbutanoic acid
amino{[(2S,5S)-5-amino-5-carboxypentan-2-yl]amino}methaniminium
The cation obtained by protonation of the imine nitrogen of (5S)-5-methyl-L-arginine.
(3R)-4-[dimethyl(trideuteriomethyl)azaniumyl]-3-formyloxybutanoate
[(4S)-4-amino-4-carboxybutyl]-(diaminomethylidene)-methylazanium
N-[(3S,4R,5S)-4,5-dihydroxy-1-oxohexan-3-yl]acetamide
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide
3-[(2R)-1-nitroso-3,4-dihydro-2H-pyridin-2-yl]pyridine
C10H11N3O (189.09020759999999)
L-homocitrulline zwitterion
An amino acid zwitterion of L-homocitrulline arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.
N(6),N(6),N(6)-trimethyl-L-lysine zwitterion
C9H21N2O2 (189.16029460000001)
A zwitterionic form of N(6),N(6),N(6)-trimethyl-L-lysinium cation arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3
L-homoarginine(1+)
A guanidinium ion that is the conjugate acid of L-homoarginine; major species at pH 7.3.
N(6)-acetimidoyl-L-lysinium(2+)
An alpha-amino-acid cation obtained by protonation of the alpha-amino and imine functions of N(6)-acetimidoyl-L-lysine
7,8-diaminononanoate cation
C9H21N2O2 (189.16029460000001)
Conjugate acid of 7,8-diaminononanoic acid.
N(6),N(6),N(6)-Trimethyl-L-lysine
C9H21N2O2 (189.16029460000001)
An alpha-amino-acid cation that is the N(6)-trimethyl derivative of L-lysine.
(3S)-3-hydroxy-L-enduracididine(1+)
An alpha-amino-acid cation obtained by deprotonation of the carboxy group and protonation of the amino and guanidino groups of (3S)-3-hydroxy-L-enduracididine.
S-prenyl-L-cysteine zwitterion
An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of S-prenyl-L-cysteine; major species at pH 7.3.
(1r,2r,3s,7s,7ar)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
3-methyl-13-azatricyclo[7.3.1.0⁵,¹³]trideca-1,4-diene
(1s,2r,8r,8ar)-1,2,8-trihydroxy-octahydroindolizin-4-ium-4-olate
3-(dimethylaminomethyl)indole; n-me
{"Ingredient_id": "HBIN008442","Ingredient_name": "3-(dimethylaminomethyl)indole; n-me","Alias": "NA","Ingredient_formula": "C12H17N2(+)","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "5457-31-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8479","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,2r,3r,7s,7as)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
(2e)-n-(4-hydroxybutyl)-3-(methylsulfanyl)prop-2-enimidic acid
(1r,2r,3r,7r,7ar)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
n-(4-hydroxybutyl)-3-(methylsulfanyl)prop-2-enimidic acid
5-[(1e)-but-1-en-1-yl]-3-methyl-2h,3h,4h,6h,7h-cyclopenta[b]pyridine
(1s,2r,3r,7s,7ar)-3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
5-carboximidoyl-4-methoxy-1h,1'h-2,2'-bipyrrole
C10H11N3O (189.09020759999999)
3-(hydroxymethyl)-hexahydro-1h-pyrrolizine-1,2,7-triol
(1r,6r,7s,8s,8as)-octahydroindolizine-1,6,7,8-tetrol
(1r,6s,7s,8s,8as)-octahydroindolizine-1,6,7,8-tetrol
4-[2-(4,5-dihydro-3h-pyrrol-2-yl)hydrazin-1-ylidene]cyclohexa-2,5-dien-1-one
C10H11N3O (189.09020759999999)